Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis. | Stem Cell Res | 2023 | 36630840 | PubTator, text mining | PubMed |
| Clinical application and detection techniques of liquid biopsy in gastric cancer. | Mol Cancer | 2023 | 36627698 | PubTator, text mining | PubMed |
| Comparative study of differentiating human pluripotent stem cells into vascular smooth muscle cells in hydrogel-based culture methods. | Regen Ther | 2023 | 36618488 | PubTator, text mining | PubMed |
| iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs. | Int J Mol Sci | 2023 | 36614321 | PubTator, text mining | PubMed |
| The Role of SOX Transcription Factors in Ageing and Age-Related Diseases. | Int J Mol Sci | 2023 | 36614288 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Transcriptional activity mediated by β-CATENIN and TCF/LEF family members is completely dispensable for survival and propagation of multiple human colorectal cancer cell lines. | Sci Rep | 2023 | 36609428 | PubTator, text mining | PubMed |
| Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer. | J Transl Med | 2023 | 36604653 | PubTator, text mining | PubMed |
| ZFP462 safeguards neural lineage specification by targeting G9A/GLP-mediated heterochromatin to silence enhancers. | Nat Cell Biol | 2023 | 36604593 | PubTator, text mining | PubMed |
| Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation. | Stem Cell Res | 2023 | 36599283 | PubTator, text mining | PubMed |
| Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. | Clin Cancer Res | 2023 | 36595540 | PubTator, text mining | PubMed |
| Cellular and transcriptional heterogeneity in the intrahepatic biliary epithelium. | Gastro Hep Adv | 2023 | 36593993 | PubTator, text mining | PubMed |
| Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping. | Mol Ther Methods Clin Dev | 2023 | 36588820 | PubTator, text mining | PubMed |
| bulkAnalyseR: an accessible, interactive pipeline for analysing and sharing bulk multi-modal sequencing data. | Brief Bioinform | 2023 | 36583521 | PubTator, text mining | PubMed |
| Feeder cells treated with ethanol can be used to maintain self-renewal and pluripotency of human pluripotent stem cells. | FEBS Open Bio | 2023 | 36537760 | PubTator, text mining | PubMed |
| Early embryonic lethality of mice lacking POLD2. | Mol Reprod Dev | 2023 | 36528861 | PubTator, text mining | PubMed |
| Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants. | Stem Cell Res | 2023 | 36528013 | PubTator, text mining | PubMed |
| Chemically defined generation of human definitive hematopoietic stem and progenitor cells. | STAR Protoc | 2023 | 36527716 | PubTator, text mining | PubMed |
| Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes. | EBioMedicine | 2023 | 36525723 | PubTator, text mining | PubMed |
| Bicuspid Aortic Valve-Associated Regulatory Regions Reveal GATA4 Regulation and Function During Human-Induced Pluripotent Stem Cell-Based Endothelial-Mesenchymal Transition-Brief Report. | Arterioscler Thromb Vasc Biol | 2023 | 36519469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=35